Key facts
- It has raised $20.0M; the latest was Later Stage VC ($500K) in Jul 2024.
- Notable investors include BioReference Health, Boomerang Catapult, Stony Lonesome Group.
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for HealthBioAI
- ·The full record, as it builds
Funding rounds
No funding rounds for HealthBioAI are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About HealthBioAI
Developer of molecular diagnostics designed for the detection and monitoring of life-threatening viral diseases. The company's diagnostics offer high throughput cellular investigation which focuses on critical life-threatening diseases such as HIV, AIDs, HPV and cervical cancer, enabling physicians to have access to single-cell testing of proteomic and genomic biomarkers in a hassle-free way.
- Sector
- Healthcare
- HQ
- Hayward, CA, United States
- Founded
- 2009
- Employees
- 22
- Website
- healthbioai.com/
- Ownership
- Privately Held (backing)
HealthBioAI doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in HealthBioAI shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on HealthBioAI in its N-PORT filings yet. We sweep new filings monthly.